Metastasis suppressor function of NM23-H1 requires its 3′-5′ exonuclease activity

International Journal of Cancer

Volumn 128, Issue 1, 2011, Pages 40-50

  Zhang, Qingbei ^a,b,c   McCorkle, Joseph R ^a,b   Novak, Marian ^a,b   Yang, Mengmeng ^a,b   Kaetzel, David M ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Exonuclease; Melanoma; Metastasis; Metastasis suppressor; NM23; Nucleoside diphosphate kinase

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; PHOSPHODIESTERASE I; PROTEIN HISTIDINE KINASE; SPLEEN EXONUCLEASE;

ARTICLE; BIOCHEMISTRY; CANCER CELL CULTURE; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXPLANT; GENE DISRUPTION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LUNG METASTASIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SITE DIRECTED MUTAGENESIS; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EXONUCLEASES; FEMALE; GLUTAMIC ACID; HISTIDINE; HUMANS; LUNG NEOPLASMS; LYSINE; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROTEIN CONFORMATION; PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 78349280274     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25307     Document Type: Article

References (36)

1. Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M,. Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 2003; 4: 51 62.
2. Steeg PS, Bevilacqua G, Kopper L, Thorgerisson UR, Talmadge JE, Liotta LA, Sobel M,. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988; 80: 200 5.
3. Hartsough MT, Steeg PS,. Nm23/nucleoside diphosphate kinase in human cancers. J Bioenerg Biomembr 2000; 32: 301 8.
4. Agarwal RP, Robinson B, Parks RE,. Nucleoside diphosphokinase from erythrocytes. Methods Enzymol 1978; 51: 376 86.
5. Sastre-Garau X, Lacombe ML, Jouve M, Veron M, Magdelenat H,. Nucleoside diphosphate kinase/NM23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int J Cancer 1992; 50: 533 8.
6. Leone A, Flatow U, VanHoutte K, Steeg PS,. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 1993; 8: 2325 33.
7. Lee HY, Lee H,. Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity. Cancer Lett 1999; 145: 93 9.
8. Wagner PD, Vu ND,. Phosphorylation of ATP-citrate lyase by nucleoside diphosphate kinase. J Biol Chem 1995; 270: 21758 64.
9. Hartsough MT, Morrison DK, Salerno M, Palmieri D, Ouatas T, Mair M, Patrick J, Steeg PS,. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 2002; 277: 32389 99.
10. Ma D, McCorkle JR, Kaetzel DM,. The metastasis suppressor NM23-H1 possesses 3′-5′ exonuclease activity. J Biol Chem 2004; 279: 18073 84.
11. Shevelev IV, H bscher U,. The 3′-5′ exonucleases. Nat Rev Mol Cell Biol 2002; 3: 1 12.
12. Yang M, Jarrett SG, Craven R, Kaetzel DM,. YNK1, the yeast homolog of human metastasis suppressor NM23, is required for repair of UV radiation- and etoposide-induced DNA damage. Mutat Res 2009; 660: 74 8.
13. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J,. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003; 112: 659 72.
14. Tseng YH, Vicent D, Zhu J, Niu Y, Adeyinka A, Moyers JS, Watson PH, Kahn CR,. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23. Cancer Res 2001; 61: 2071 9.
15. Otsuki Y, Tanaka M, Yoshii S, Kawazoe N, Nakaya K, Sugimura H,. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci USA 2001; 98: 4385 90.
16. Subramanian C, Cotter MA, Robertson ES,. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat Med 2001; 7: 350 5.
17. D'Angelo A, Garzia L, Andre A, Carotenuto P, Aglio V, Guardiola O, Arrigoni G, Cossu A, Palmieri G, Aravind L, Zollo M,. Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis. Cancer Cell 2004; 5: 137 49.
18. Galasso A, Zollo M,. The Nm23-H1-h-Prune complex in cellular physiology: a tip of the iceberg protein network perspective. Mol Cell Biochem 2009; 329: 149 59.
19. Gilles AM, Presecan E, Vonica A, Lascu I,. Nucleoside diphosphate kinase from human erythrocytes. Structural characterizatioin of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 1991; 266: 8784 9.
20. Postel EH, Abramczyk BM, Levit MN, Kyin S,. Catalysis of DNA cleavage and nucleoside triphosphate synthesis by NM23-H2/NDP kinase share an active site that implies a DNA repair function. Proc Natl Acad Sci USA 2000; 97: 14194 9.
21. Postel EH, Abramczyk BA, Gursky SK, Xu Y,. Structure-based mutational and functional analysis identify human NM23-H2 as a multifunctional enzyme. Biochemistry 2002; 41: 6330 7.
22. Morera S, Lacombe ML, Xu Y, LeBras G, Janin J,. X-ray structure of human nucleoside diphosphate kinase B complexed with GDP at 2 A resolution. Structure 1995; 3: 1307 14.
23. Freije JM, Blay P, MacDonald NJ, Manrow RE, Steeg PS,. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. J Biol Chem 1997; 272: 5525 32.
24. Rosengard AM, Krutzch HC, Shearn A, Biggs JR, Barker E, Margulies IMK, King CR, Liotta LA, Steeg PS,. Reduced Nm23/Awd protein in tumor metastases and aberrant Drosophila development. Nature 1989; 342: 177 80.
25. Yoon JH, Singh P, Lee DH, Qiu J, Cai S, O'Connor TR, Chen Y, Shen B, Pfeifer GP,. Characterization of the 3′ > 5′ exonuclease activity found in human nucleoside diphosphate kinase 1 (NDK1) and several of its homologues. Biochemistry 2005; 44: 15774 86.
26. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR,. Site-directed mutagenesis by overlap extension using the PCR. Gene 1989; 77: 51 9.
27. Ma D, Xing Z, Liu B, Pedigo N, Zimmer S, Bai Z, Postel E, Kaetzel DM,. NM23-H1 cleaves and represses transcriptional activity of nuclease- hypersensitive elements in the PDGF-A promoter. J Biol Chem 2002; 277: 1560 7.
28. Postel EH,. Cleavage of DNA by human NM23-H2/nucleoside diphosphate kinase involves formation of a covalent protein-DNA complex. J Biol Chem 1999; 274: 22821 9.
29. Liu B, Maul RS, Kaetzel DM, Jr,. Repression of platelet-derived growth factor A-chain gene transcription by an upstream silencer element. J Biol Chem 1996; 271: 26281 90.
30. Kath R, Jambrosic JA, Holland L, Rodeck U, Herlyn M,. Development of invasive and growth factor-independent cell variants from primary human melanomas. Cancer Res 1991; 51: 2205 11.
31. Schilling D, Reid JDI, Hujer A, Morgan D, DeMoll E, Bummer P, Fenstermaker RA, Kaetzel DM,. Loop III region of platelet-derived growth factor (PDGF) B-chain mediates binding to PDGF receptors and heparin. Biochem J 1998; 333: 637 44.
32. Postel EH, Weiss VH, Beneken J, Kirtane A,. Mutational analysis of NM23-H2/NDP kinase identifies the structural domains critical to recognition of a c-myc regulatory element. Proc Natl Acad Sci USA 1996; 93: 6892 7.
33. MacDonald NJ, De La Rosa A, Benedict MA, Freije JM, Krutsch H, Steeg PS,. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 1993; 268: 25780 9.
34. Herlyn D, Iliopoulos D, Jensen PJ, Parmiter A, Baird J, Hotta H, Adachi K, Ross AH, Jambrosic J, Koprowski H,. In vitro properties of human melanoma cells metastatic in nude mice. Cancer Res 1990; 50: 2296 302.
35. MacDonald NJ, Freije JM, Stracke ML, Manrow RE, Steeg PS,. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells. J Biol Chem 1996; 271: 25107 16.
36. Zhou Q, Yang X, Zhu D, Ma L, Zhu W, Sun Z, Yang Q,. Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability. Biochem Biophys Res Commun 2007; 356: 348 53.